Brief: Medincell H1 Revenues EUR 11.6 Mln
Dec 9 (Reuters) - Medincell SA MEDCL.PA: PUBLISHES ITS CONSOLIDATED HALF-YEAR FINANCIAL RESULTS H1 REVENUES EUR 11.6 MILLION, UP 35% YOY H1 TOTAL INCOME EUR 14.1 MILLION, UP 50% YOY H1 OPERATING EXPENSES EUR 20.8 MILLION, UP 22% YOY NEW DRUG APPLICATION SUBMITTED BY TEVA TO FDA FOR OLANZAPINE LAI ON DECEMBER 9, 2025 Source text: ID:nBw4qgkhsa Further company coverage: MEDCL.PA (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))